Posted inClinical Trials, COVID-19, Infections, Oncology Yeliva: New Drug for COVID-19 February 19, 2022September 8, 2022 Oral opaganib will reduce the likelihood of death and accelerate recovery in hospitalized patients with COVID-19.
